AbbVie Inc.

GPTKB entity

Statements (64)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Allergan's_Kythera_Biopharmaceuticals
gptkb:Immunomedics
gptkb:Alder_BioPharmaceuticals
gptkb:Neurocrine_Biosciences
gptkb:Mavenclad
gptkb:Allergan's_Natrelle
gptkb:Allergan's_LifeCell
gptkb:Celerion
gptkb:Allergan's_Solstice_Neurosciences
gptkb:Allergan's_SkinMedica
Aimmune Therapeutics
Allergan
Kite Pharma
Rinvoq
Stemcentrx
Allergan Aesthetics
Allergan's Aesthetics portfolio
Allergan's Botox
Allergan's CoolSculpting
Allergan's Juvederm
Allergan's_Avanir_Pharmaceuticals
Allergan's_Zymeworks
gptkbp:awards Best Places to Work
Fortune 500 company
DiversityInc Top 50
Human_Rights_Campaign_Corporate_Equality_Index_score_of_100
Top_Employer_in_the_U.S.
gptkbp:CEO gptkb:Richard_A._Gonzalez
gptkbp:clinicalTrials Phase 3 trials for Rinvoq
Phase 3 trials for Skyrizi
Phase 3 trials for Imbruvica
Phase 3 trials for Venclexta
over 100 clinical trials ongoing
gptkbp:employees approximately 50,000
gptkbp:founded 2013
gptkbp:founder gptkb:Richard_A._Gonzalez
gptkbp:headquarters gptkb:North_Chicago,_Illinois
https://www.w3.org/2000/01/rdf-schema#label AbbVie Inc.
gptkbp:industry pharmaceuticals
gptkbp:market approximately $200 billion (2022)
gptkbp:partnerships gptkb:Mayo_Clinic
gptkb:Duke_University
gptkb:Harvard_University
gptkb:University_of_California,_San_Francisco
gptkb:University_of_Chicago
gptkbp:patentCitation over 50,000 patents filed
gptkbp:philanthropy AbbVie_Foundation
gptkbp:products gptkb:Humira
gptkbp:research_focus oncology
neuroscience
immunology
virology
gptkbp:revenue approximately $56 billion (2022)
gptkbp:stockExchange ABBV
gptkbp:subsidiary gptkb:AbbVie_S.r.l.
gptkb:AbbVie_Biotherapeutics
AbbVie_Ltd.
AbbVie_Deutschland_GmbH
AbbVie_Japan,_Ltd.
gptkbp:sustainability focus on community engagement
focus on environmental responsibility
focus on diversity and inclusion
focus on access to healthcare